Eric T Oliver
Overview
Explore the profile of Eric T Oliver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lyu S, Oliver E, Dispenza M, Chichester K, Hoffman J, MacGlashan D, et al.
J Allergy Clin Immunol Pract
. 2024 Aug;
12(11):3025-3033.e6.
PMID: 39117269
Background: Vancomycin infusion reaction (VIR), reportedly mediated through Mas-Related G Protein-Coupled Receptor-X2, is the primary vancomycin-induced immediate drug reaction. Clinically, distinguishing the underlying drug-induced immediate drug reaction mechanisms is crucial...
2.
Oliver E, Saini S
Immunol Allergy Clin North Am
. 2024 Jun;
44(3):421-438.
PMID: 38937007
Urticaria, also known as hives, is a common condition thought to affect up to 20% of individuals worldwide in their lifetime. This skin condition is characterized by the appearance of...
3.
Chu A, Rayner D, Chu X, Chen L, Dong A, Waserman S, et al.
Ann Allergy Asthma Immunol
. 2024 Jun;
133(4):437-444.e18.
PMID: 38901542
Background: Topical corticosteroids are widely used as a treatment for itch and wheals (urticaria), but their benefits and harms are unclear. Objective: To systematically synthesize the benefits and harms of...
4.
Bellamy C, Chichester K, Saini S, Oliver E
Clin Exp Allergy
. 2024 Jun;
54(9):703-705.
PMID: 38887172
No abstract available.
5.
Rayner D, Liu M, Chu A, Chu X, Guyatt G, Oykhman P, et al.
J Allergy Clin Immunol
. 2024 Jun;
154(4):996-1007.
PMID: 38852861
Background: The benefits and harms of adding antileukotrienes to H antihistamines (AHs) for the management of urticaria (hives, itch, and/or angioedema) remain unclear. Objective: We sought to systematically synthesize the...
6.
Chu X, Wang J, Ologundudu L, Brignardello-Petersen R, Guyatt G, Oykhman P, et al.
J Allergy Clin Immunol Pract
. 2024 Apr;
12(7):1879-1889.e8.
PMID: 38642709
Background: Short courses of adjunctive systemic corticosteroids are commonly used to treat acute urticaria and chronic urticaria flares (both with and without mast cell-mediated angioedema), but their benefits and harms...
7.
Villanueva C, Barksdale K, Owolabi T, Bridges D, Chichester K, Saini S, et al.
Front Allergy
. 2024 Apr;
5:1373511.
PMID: 38601026
Mast cells are activated through a variety of different receptors to release preformed granules and mediators synthesized . However, the physiology and function of mast cells are not fully understood....
8.
Johal K, Chichester K, Oliver E, Devine K, Bieneman A, Schroeder J, et al.
J Allergy Clin Immunol
. 2021 Mar;
147(6):2271-2280.e8.
PMID: 33713769
Background: The mechanisms underlying disease pathogenesis in chronic spontaneous urticaria (CSU) and improvement with omalizumab are incompletely understood. Objectives: This study sought to examine whether the rate of clinical remission...
9.
Shtessel M, Limjunyawong N, Oliver E, Chichester K, Gao L, Dong X, et al.
J Invest Dermatol
. 2020 Aug;
141(3):678-681.e2.
PMID: 32771471
No abstract available.
10.
Oliver E, Hogan M
J Allergy Clin Immunol Pract
. 2020 Jul;
8(7):2370-2371.
PMID: 32620436
No abstract available.